6,526
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights

Pages 45-52 | Received 01 Apr 2011, Published online: 31 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. Rana Mohammed & Mohammed Al-Shehri. (2012) Postural Hypotension in Parkinson’s disease. Journal of Parkinsonism and Restless Legs Syndrome 2, pages 32-33.
Read now

Articles from other publishers (17)

Robert A. Hauser, William G. Ondo, Yi Zhang, Alyssa Bowling, Bradford Navia, Eric Pappert & Stuart H. Isaacson. (2023) Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary?. Journal of Parkinson's Disease 13:3, pages 403-414.
Crossref
Susanne A. Schneider, Anita Hennig & Davide Martino. (2021) Relationship between COVID‐19 and movement disorders: A narrative review. European Journal of Neurology 29:4, pages 1243-1253.
Crossref
Nicola L. Brice, Hans H. Schiffer, Holger Monenschein, Victoria J. Mulligan, Keith Page, Justin Powell, Xiao Xu, Toni Cheung, J. Russell Burley, Huikai Sun, Louise Dickson, Sean T. Murphy, Nidhi Kaushal, Steve Sheardown, Jason Lawrence, Yun Chen, Darian Bartkowski, Anne Kanta, Joseph Russo, Natalie Hosea, Lee A. Dawson, Stephen H. Hitchcock & Mark B. Carlton. (2021) Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics 377:3, pages 407-416.
Crossref
Amitha Dhingra, A. Umair Janjua, Laura Hack, Gabriella Waserstein, Justin Palanci & Adriana P. Hermida. (2020) Exploring Nonmotor Neuropsychiatric Manifestations of Parkinson Disease in a Comprehensive Care Setting. Journal of Geriatric Psychiatry and Neurology 34:3, pages 181-195.
Crossref
Zvonimir Petric, Irena Žuntar, Predrag Putnik & Danijela Bursać Kovačević. (2020) Food–Drug Interactions with Fruit Juices. Foods 10:1, pages 33.
Crossref
Sheng-Yu Lee, Tzu-Yun Wang, Shiou-Lan Chen, Yun-Hsuan Chang, Po-See Chen, San-Yuan Huang, Nian-Sheng Tzeng, Liang-Jen Wang, I-Hui Lee, Kao-Ching Chen, Yen-Kuang Yang, Jau-Shyong Hong & Ru-Band Lu. (2020) Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial. International Journal of Bipolar Disorders 8:1.
Crossref
Manon Auffret, Sophie Drapier & Marc Vérin. (2018) Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance. Clinical Drug Investigation 38:4, pages 287-312.
Crossref
Aileen Cronin & Maura Grealy. (2017) Neuroprotective and Neuro-restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson’s Disease. Neuroscience 367, pages 34-46.
Crossref
Cesar Soria-Fregozo, Maria Isabel Perez-Vega, Juan Francisco Rodríguez-Landa, León Jesús Germán-Ponciano, Rosa Isela García-Ríos & Armando Mora-Perez. 2017. Serotonin - A Chemical Messenger Between All Types of Living Cells. Serotonin - A Chemical Messenger Between All Types of Living Cells.
Muhammed Khairujjaman Mazumder, Nivedita Bhattacharjee & Anupom Borah. (2015) Garcinol prevents hyperhomocysteinemia and enhances bioavailability of L-DOPA by inhibiting catechol-O-methyltransferase: an in silico approach. Medicinal Chemistry Research 25:1, pages 116-122.
Crossref
Michel Panisset, Jack J. Chen, Sean H. Rhyee, Jill Conner & Julie Mathena. (2014) Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO). Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:12, pages 1250-1258.
Crossref
F.I. Tarazi, Z.T. Sahli, M. Wolny & S.A. Mousa. (2014) Emerging therapies for Parkinson's disease: From bench to bedside. Pharmacology & Therapeutics 144:2, pages 123-133.
Crossref
Jack J. Chen & Laura Marsh. (2013) Anxiety in Parkinson’s disease: identification and management. Therapeutic Advances in Neurological Disorders 7:1, pages 52-59.
Crossref
A. Sampedro, E. Tarragón, J. E. Yuste, F. Ros-Bernal, V. Ortiz, C. M. Campuzano, A. Gómez, C. M. Ros, E. Fernández-Villalba & M. T. Herrero. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1311 1340 .
Sabine Hellwig, Annabelle Kreft, Florian Amtage, Oliver Tüscher, Oliver H. Winz, Bernhard Hellwig, Cornelius Weiller, Wolfgang A. Weber, Werner Vach & Philipp T. Meyer. (2013) 123 I-Iodobenzamide SPECT Is Not an Independent Predictor of Dopaminergic Responsiveness in Patients with Suspected Atypical Parkinsonian Syndromes . Journal of Nuclear Medicine 54:12, pages 2081-2086.
Crossref
Jack J. Chen. 2013. Handbook of Parkinson’s Disease. Handbook of Parkinson’s Disease 171 191 .
Sheng-Yu Lee, Shiou-Lan Chen, Yun-Hsuan Chang, Shih-Heng Chen, Chun-Hsieh Chu, San-Yuan Huang, Nian-Sheng Tzeng, Chen-Lin Wang, I Hui Lee, Tzung Lieh Yeh, Yen Kuang Yang & Ru-Band Lu. (2012) The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder. Journal of Affective Disorders 138:3, pages 295-300.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.